| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 70.4 | 63.0 | 53.6 |
| Other income | 2.6 | 4.5 | 3.0 |
| Total income | 72.9 | 67.5 | 56.6 |
| Profit before exceptional items & tax | 22.0 | 16.6 | 14.4 |
| Exceptional items | 0.0 | 0.8 | 0.0 |
| Profit before tax | 22.0 | 17.4 | 14.4 |
| Net profit | 16.3 | 14.5 | 10.2 |
| Operating margin | 30.2% | 25.8% | 25.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +59.80% |
|---|---|
| Net profit, quarter on quarter | +12.40% |
| Revenue, year on year | +31.30% |
| Operating profit, year on year | +70.20% |
| Operating profit, quarter on quarter | +60.30% |
BSE results filing, NSE: INDOBORAX. Figures extracted from the filing.
Indo Borax & Chemicals Ltd: key numbers
- Share price
- ₹480.90
- Market cap
- ₹1,543 Cr
- Revenue (annual)
- ₹215.4 Cr
- Net profit (annual)
- ₹50.27 Cr
- P/E (TTM)
- 27.4×Sector 36.8×
- Promoter holding
- 38.41%+7.61% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Borax & Chemicals Ltd
All →Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
- Value
- ₹225.0 Cr
Indo Borax & Chemicals Annual General Meeting
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax & Chemicals Earnings Call Transcript: Key Takeaways
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
- Call
- Guides 19% growth
Indo Borax & Chemicals Investor Presentation: Key Takeaways
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Credit Rating
Indo Borax & Chemicals Ltd received a credit rating update from India Ratings, placing its bank loan facilities on 'Rating Watch with Negative Implications'.
Indo Borax & Chemicals Other Announcement
Indo Borax & Chemicals Ltd. is relocating its corporate office to a new premises in Andheri (East), Mumbai, effective September 15, 2026.